Ansornitinib
Ansornitinib (ANG-3070) is an oral small molecule inhibitor targeting PDGFR and VEGFR2 (KDR), exhibiting antifibrotic activity. It is utilized in preclinical research to investigate fibrotic diseases, with studies demonstrating its efficacy in both cellular assays and animal models of fibrosis.
Product Specifications
CAS Number
1448874-96-1
Product Name Alternative
PDGFR, VEGFR, ANG3070, ANG-3070, ANG 3070
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.24% (May vary between batches)
Solubility
DMSO:20 mg/mL (37 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.25 mM)
Smiles
C (\NC1=CC=C (N (C (CN2CCN (C) CC2) =O) C) C=C1) (=C\3/C=4C (NC3=O) =NC (C (OC) =O) =CC4) /C5=CC=CC=C5
Molecular Formula
C30H32N6O4
Molecular Weight
540.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6396204-01 0.1 mL
TCF2 (Hepatocyte Nuclear Factor 1-beta, HNF-1-beta, HNF-1B, Homeoprotein LFB3, Transcription Factor 2, TCF-2, Variant Hepatic Nuclear Factor 1, vHNF1, HNF1B) APC
Sign In for Pricing
View Details MBS6396204-02 5x 0.1 mL
TCF2 (Hepatocyte Nuclear Factor 1-beta, HNF-1-beta, HNF-1B, Homeoprotein LFB3, Transcription Factor 2, TCF-2, Variant Hepatic Nuclear Factor 1, vHNF1, HNF1B) APC
Sign In for Pricing
View Details 
bsm-61318R-PE-Cy7-01 20 µL
CaMK2 alpha Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details bsm-61318R-PE-Cy7-02 100 µL
CaMK2 alpha Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details